Zoetis (MEX:ZTS) Quality Rank


MEX:ZTS Zoetis Inc MEX:ZTS
73 GF Score
Price MXN1,320.00
GF Value MXN3,396.78
Valuation Significantly Undervalued
View Full Analysis

What is Zoetis Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Zoetis Quality Rank Related Terms

MEX:ZTS
73GF Score
Zoetis Inc MEX:ZTS
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zoetis (MEX:ZTS) Overvalued in 2026?

Based on GuruFocus' analysis, Zoetis stock appears to be undervalued. The current stock price of MXN1,320.00 is trading 61.1% below its estimated GF Value™ of MXN3,396.78. GuruFocus considers Zoetis to be Significantly Undervalued.

Key valuation signals for MEX:ZTS:

  • Quality Rank:
  • GF Value™: MXN3,396.78 vs. price of MXN1,320.00 (61.1% below fair value)
  • GF Score™: 73/100

No single metric tells the full story. See the MEX:ZTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zoetis Business Description

Address 10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
73GF Score

Get the complete analysis for MEX:ZTS

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,320.00
Price
MXN3,396.78
GF Value